TIRZ20 (20mg)
TIRZ20 is a dual GIP and GLP-1 receptor agonist designed for metabolic health and weight management. By acting on both incretin pathways, it improves insulin sensitivity, slows gastric emptying, and reduces appetite to support steady, sustained fat loss. Its once-weekly dosing makes it a convenient option for long-term protocols focused on body composition and blood sugar control.
Product Highlights
Dosing Instructions
Reconstitute with bacteriostatic water as directed. Administer via subcutaneous injection as per your protocol. Begin conservatively and adjust only under appropriate guidance.
Compound Information
Recommended Dose: 2.5–7.5 mg per week.
Frequency: Once per week, titrated every 4 weeks.
Administration: Subcutaneous injection.
Molecular Weight: 4813.49 g/mol.
Formula: C225H348N48O68.
Half-Life: Approx. 5 days.
Note: All peptide products are for research purposes only. Information provided is educational and not a substitute for medical advice.
Need help with mixing your peptides? Use our peptide mixing calculator below.
Product Description
Additional Information
| Weight | 6 g |
|---|---|
| Dimensions | 3.7 × 1.5 × 1.5 in |
